| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alternatively activated macrophage-derived secretome stimulates ovarian cancer spheroid spreading through a JAK2/STAT3 pathway
|
Fogg, Kaitlin C.
|
|
|
458 |
C |
p. 92-101
|
artikel
|
| 2 |
Block of NF-kB signaling accelerates MYC-driven hepatocellular carcinogenesis and modifies the tumor phenotype towards combined hepatocellular cholangiocarcinoma
|
He, Jiajia
|
|
|
458 |
C |
p. 113-122
|
artikel
|
| 3 |
COMPASS Ascending: Emerging clues regarding the roles of MLL3/KMT2C and MLL2/KMT2D proteins in cancer
|
Fagan, Richard J.
|
|
|
458 |
C |
p. 56-65
|
artikel
|
| 4 |
Editorial Board
|
|
|
|
458 |
C |
p. ii
|
artikel
|
| 5 |
Etiology, cancer stem cells and potential diagnostic biomarkers for esophageal cancer
|
Liu, Kuancan
|
|
|
458 |
C |
p. 21-28
|
artikel
|
| 6 |
FOXK transcription factors: Regulation and critical role in cancer
|
Liu, Ying
|
|
|
458 |
C |
p. 1-12
|
artikel
|
| 7 |
Impact of hypoxic tumor microenvironment and tumor cell plasticity on the expression of immune checkpoints
|
Lequeux, Audrey
|
|
|
458 |
C |
p. 13-20
|
artikel
|
| 8 |
Individualized precision treatment: Targeting TAM in HCC
|
Li, Zhixuan
|
|
|
458 |
C |
p. 86-91
|
artikel
|
| 9 |
Nanoparticles for nucleic acid delivery: Applications in cancer immunotherapy
|
Mukalel, Alvin J.
|
|
|
458 |
C |
p. 102-112
|
artikel
|
| 10 |
Network-based cancer precision medicine: A new emerging paradigm
|
Tan, Aidi
|
|
|
458 |
C |
p. 39-45
|
artikel
|
| 11 |
Novel ROR1 inhibitor ARI-1 suppresses the development of non-small cell lung cancer
|
Liu, Xuesha
|
|
|
458 |
C |
p. 76-85
|
artikel
|
| 12 |
NRF2 antioxidant response protects against acidic bile salts-induced oxidative stress and DNA damage in esophageal cells
|
Peng, Dunfa
|
|
|
458 |
C |
p. 46-55
|
artikel
|
| 13 |
PAK4 regulates stemness and progression in endocrine resistant ER-positive metastatic breast cancer
|
Santiago-Gómez, Angélica
|
|
|
458 |
C |
p. 66-75
|
artikel
|
| 14 |
RETRACTED: IP1867B suppresses the Insulin-like Growth Factor 1 Receptor (IGF1R) ablating Epidermal Growth Factor Receptor inhibitor resistance in adult high grade gliomas
|
Mihajluk, K.
|
|
|
458 |
C |
p. 29-38
|
artikel
|
| 15 |
Targeting the tumour immune microenvironment for cancer therapy in human gastrointestinal malignancies
|
Zhang, Yunbin
|
|
|
458 |
C |
p. 123-135
|
artikel
|
Tijdschrift beschrijving